A carregar...
RANKL/RANK Pathway and Its Inhibitor RANK-Fc in Uterine Leiomyoma Growth
CONTEXT: Uterine leiomyomas are the most common type of gynecologic tumor in women. OBJECTIVE: To determine the role of the cytokine receptor activator of nuclear factor κ-Β ligand (RANKL); its receptor, receptor activator of nuclear factor κ-Β (RANK); and the RANKL/RANK pathway inhibitor RANK-Fc in...
Na minha lista:
| Publicado no: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276708/ https://ncbi.nlm.nih.gov/pubmed/29741640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2017-01585 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|